From cyclic AMP to cytokines. Pentoxifylline : present and future. International congressCAPRON, Loic; HAKIM, Jacques; WAUTIER, Jean-Luc et al.Journal of cardiovascular pharmacology. 1995, Vol 25, issn 0160-2446, 152 p., SUP2Conference Proceedings

Impairment of polymorphonuclear neutrophil function in HIV-infected patientsELBIM, C; PREVOT, M. H; BOUSCARAT, F et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S66-S70, issn 0160-2446, SUP2Conference Paper

Pentoxifylline for the treatment of HIV infection and its complicationsDEZUBE, B. J; LEDERMAN, M. M.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S139-S142, issn 0160-2446, SUP2Conference Paper

Pharmacologic approaches to the treatment of atherosclerotic arterial obstructionCAPRON, L.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S40-S43, issn 0160-2446, SUP2Conference Paper

Cytokines and thrombosisDOSQUET, C; WEILL, D; WAUTIER, J.-L et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S13-S19, issn 0160-2446, SUP2Conference Paper

Effect of pentoxifylline on apoptosis of cultured cellsBELLOC, F; JALOUSTRE, C; DUMAIN, P et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S71-S74, issn 0160-2446, SUP2Conference Paper

Pharmacologic treatment of venous leg ulcersDORMANDY, J. A.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S61-S65, issn 0160-2446, SUP2Conference Paper

Cytokines, phagocytes, and pentoxifyllineMANDELL, G. L.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S20-S22, issn 0160-2446, SUP2Conference Paper

Pentoxifylline and critical leg ischemiaCOLGAN, M.-P; MOORE, D. J; SHANIK, G. D et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S58-S60, issn 0160-2446, SUP2Conference Paper

Pentoxifylline in severe inflammatory response syndromeGRANINGER, W; WENISCH, C.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S134-S138, issn 0160-2446, SUP2Conference Paper

Prevention studies with pentoxifylline : New clinical projectsEUGENE-JOLCHINE, I; MILPIED, N.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S143-S146, issn 0160-2446, SUP2Conference Paper

Neutrophil degranulation related to the reperfusion of ischemic human heart during cardiopulmonary bypassDHOTE-BURGER, P; VUILLEMINOT, A; LECOMPTE, T et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S124-S129, issn 0160-2446, SUP2Conference Paper

Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shockBARROSO-ARANDA, J; ZWEIFACH, B. W; MATHISON, J. C et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S23-S29, issn 0160-2446, SUP2Conference Paper

Pentoxifylline and intermittent claudication : Review of clinical trials and cost-effectiveness analysesGILLINGS, D. B.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S44-S50, issn 0160-2446, SUP2Conference Paper

Pentoxifylline and lung ischemia-reperfusion injury : Application to lung transplantationCHAPELIER, A; REIGNIER, J; MAZMANIAN, M et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S130-S133, issn 0160-2446, SUP2Conference Paper

Cytokines regulate vascular functions related to stability of the atherosclerotic plaqueLIBBY, P; SUKHOVA, G; LEE, R. T et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S9-S12, issn 0160-2446, SUP2Conference Paper

Leukocyte activation study during occlusive arterial disease of the lower limb : effect of pentoxifylline infusionFOSSAT, C; FABRE, D; ALIMI, Y et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S96-S100, issn 0160-2446, SUP2Conference Paper

Leukocyte adherence in an ischemic muscle perfused by a collateral circulationXIN HOU; BAUDRY, N; LENOBLE, M et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S119-S123, issn 0160-2446, SUP2Conference Paper

Pentoxifylline selectivity inhibits tumor necrosis factor synthesis in the arterial wallBERNARD, C; BARNIER, P.K; MERVAL, R et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S30-S33, issn 0160-2446, SUP2Conference Paper

Activated leukocytes, endothelial cells, and effects of pentoxifylline : Observations by VEC-DIC microscopyTOMITA, M; FUKUUCHI, Y; TERAKAWA, S et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S34-S39, issn 0160-2446, SUP2Conference Paper

Influence of pentoxifylline on membrane thrombomodulin levels in endothelial cells submitted to hypoxic conditionsSEIGNEUR, M; DUFOURCQ, P; BELLOC, F et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S85-S87, issn 0160-2446, SUP2Conference Paper

Pharmacologic control of intracellular signaling pathways : From research to therapyHAKIM, J.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S106-S113, issn 0160-2446, SUP2Conference Paper

Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifyllineBIENVENU, J; DOCHE, C; GUTOWSKI, M.-C et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S80-S84, issn 0160-2446, SUP2Conference Paper

Expression of elastase and fibrin in venous leg ulcer biopsies : a pilot study of pentoxifylline versus placeboMIRSHAHI, S; SORIA, J; MIRSHAHI, M et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S101-S105, issn 0160-2446, SUP2Conference Paper

Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cellsBENBERNOU, N; ESNAULT, S; POTRON, G et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S75-S79, issn 0160-2446, SUP2Conference Paper